tingenone has been researched along with celastrol in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Farnsworth, NR; Ngassapa, O; Pezzuto, JM; Soejarto, DD | 1 |
Chan, WK; Chang, MN; He, W; Huang, FC; Moriarty, KJ; Yu, KT; Zhang, DC; Zilberstein, A | 1 |
Hirasawa, Y; Morita, H; Muto, A; Sekita, S; Shirota, O; Yoshida, T | 1 |
Chang, JS; Kim, YM; Lee, JY; Lee, WS; Park, KH; Park, SJ; Rho, MC; Ryu, YB; Seo, WD | 1 |
Brooks, WH; Chen, L; Daniel, KG; Guida, WC; Lawrence, HR; Lawrence, NJ; Scott, LM; Sebti, SM; Wu, J | 1 |
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
6 other study(ies) available for tingenone and celastrol
Article | Year |
---|---|
Quinone-methide triterpenes and salaspermic acid from Kokoona ochracea.
Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Humans; Leukemia P388; Magnetic Resonance Spectroscopy; Mice; Philippines; Plants, Medicinal; Triterpenes; Tumor Cells, Cultured | 1994 |
Novel cytokine release inhibitors. Part I: Triterpenes.
Topics: Animals; Cytokines; Humans; In Vitro Techniques; Inflammation; Molecular Structure; Rats; Triterpenes | 1998 |
Antimitotic quinoid triterpenes from Maytenus chuchuhuasca.
Topics: Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Humans; Maytenus; Molecular Structure; Pentacyclic Triterpenes; Plants, Medicinal; Triterpenes; Tubulin | 2008 |
SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii.
Topics: Antiviral Agents; Benzoquinones; Models, Molecular; Plant Extracts; Severe acute respiratory syndrome-related coronavirus; Tripterygium; Triterpenes | 2010 |
Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs.
Topics: Antineoplastic Agents, Hormonal; Estramustine; Humans; Models, Molecular; Neoplasms; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Structure-Activity Relationship; Triterpenes | 2011 |
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |